Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of the Clinical Response Between tDCS and Dapoxetine, Define a Very Effective Therapeutic Target, That Improves the LPE in the Medium Long Term

NCT04850703 is registered in ClinicalTrials.gov with Moises Domingo as lead sponsor.

NCT NCT04850703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04850703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of the Clinical Response Between tDCS and Dapoxetine, Define a Very Effective Therapeutic Target, That Improves the LPE in the Medium Long Term
Lead sponsor
Moises Domingo
Phase
Phase 1/2
Overall status
Completed
Start date
February 2, 2021
Completion date
February 4, 2023
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ejaculation, sexual dysfunction